个人简历

学术团体和社会兼职：谢幸，男，1955年7月出生，教授，主任医师，博士生导师。国家重点（培育）学科和浙江省重点学科－妇产科学学科带头人。浙江省有突出贡献中青年专家。现为浙江省女性生殖健康重点实验室主任、浙江省宫颈疾病诊治中心主任。现为中华医学会妇科肿瘤分会副主任委员、中华医学会妇产科学分会常委、中华预防医学会妇女保健学会常委、中国抗癌协会妇科肿瘤专业委员会委员、浙江省医师协会妇产科学分会会长、浙江省抗癌协会妇科肿瘤专业委员会主任委员、浙江医学会妇产科学分会主任委员、浙江省预防医学会妇幼保健院管理专业委员会主任委员。学历和研究经历：1983年毕业于浙江大学医学院（原浙江医科大学）。1988获浙江大学医学院妇科肿瘤专业硕士学位，曾赴德国、美国等国留学。

研究领域

妇科肿瘤基础研究，包括卵巢癌与腹腔免疫缺陷及其机制、宫颈癌发生的免疫学和分子遗传学机制、妊娠滋养细胞疾病发病的分子遗传学机制等。""

近期论文

1.Shi YF, Xie X, Zhao CL, Ye DF, Lu SM, Hor JJ, Pao CC. Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer 1996;73(10):1216-1219. \r
\r
2.Stevenson AFG, Xie X, Kunstmann P. Cell culture of biopised endometrial after danazol/hormonal therapy: a study of growth features and fertility effects. Indian J Exper Biolo 2000; 38:1192-1200. \r
\r
3.Ye D, Xie X, Lu W, Chen H, Cheng B. Growth inhibition of interleukin-2 receptor gene-tranduced peripheral blood lymphocytes on human ovarian cancer cells. Chin Med J (English) 2001; 114(3): 303-307. \r
\r
4.Dong MY, Xie X, Wang ZP, He J, Zhou JH, Cheng Q. Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy. Gynecol Obstet Invest 2002; 54(4):191-195. \r
\r
5.Xie X, Lu WG, Ye DF, Chen HZ, Fu YF. The value of curettage in diagnosis of endometrial hyperplasia. Gynecol Oncol 2002;84 (1):135-139. \r
\r
6.Chen HZ, Ye DF, Xie X, Chen B, Lu WG. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol Oncol 2004; 94(3):630-635. \r
\r
7.Wang H, Xie X, Lu WG, Ye DF, Chen HZ, Li X, Cheng Q. Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway. Life Sci 2004; 74(14):1739-1749. \r
\r
8.Xie X, Ye D, Chen H, Lu W, Cheng B, Zhong H. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma. Int J Gynaecol Obstet 2004; 85(2):151-158. \r
\r
9.Xie X, Ye DF, Chen HZ Lu WG, Fu YF, Cheng B, Zhu H. Effect of interleukin-7 gene transaction into ovarian carcinoma cell line SKOV3 in vitro and in vivo. Gynecol Oncol 2004; 92(2):578-585. \r
\r
10.Ye F, Chen HZ, Xie X, Ye DF, Lu WG, Ding ZM. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. Gynecol Oncol 2004; 94(1):125-133. \r
\r
11.Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 2004; 112(3):465-469. \r
\r
12.Zhang M, Xie X, Lee AH, Binns CW. Sedentary behaviours and epithelial ovarian cancer. Cancer Cause Control 2004; 15:83-89. \r
\r
13.Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in Southeast China. Nutr Cancer 2004; 49(2):125-130. \r
\r
14.Zhang M, Xie X, Lee AH, Binns CW. Prolonged lactation reduced ovarian cancer risk in Chinese women. Eur J Cancer Prev 2004; 13:499-502. \r
\r
15.Chen HZ, Ye DF, Xie X, Lu W, Zhu C, Chen X. PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles. J Soc Gynecol Investig 2005;12:214-217. \r
\r
16.Chen HZ, Ye DF, Xie X, Lu W, Zhu C, Chen X. Mismatch repair gene promoter methylation and expression in hydatidiform moles. Arch Gynecol Obstet 2005; 272(1):35-39. \r
\r
17.Zhang M, Xie X, Lee AH, Binns CW, Holman CDJ. Body mass index in relation to ovarian cancer survival. Cancer Epidem Biomar 2005; 14(5):1307-1310.